LOSS PER SHARE

9 Months Ended

Sep. 30, 2019

Loss per share attributable to Bausch Health Companies Inc. were calculated as follows:



	Three Months Ended September 30,						Nine Months Ended September 30,
(in millions, except per share amounts)	2019			2018			2019			2018
Net loss attributable to Bausch Health Companies Inc.	$	(49	)	$	(350	)	$	(272	)	$	(3,804	)

Basic and diluted weighted-average common shares outstanding	352.4			351.5			351.9			351.1

Basic and diluted loss per share attributable to Bausch Health Companies Inc.	$	(0.14	)	$	(1.00	)	$	(0.77	)	$	(10.83	)

During the three and nine months ended September 30, 2019 and 2018, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 4,453,000 and 4,238,000 common shares for the three months ended September 30, 2019 and 2018, respectively, and approximately 4,589,000 and 3,323,000 common shares for the nine months ended September 30, 2019 and 2018, respectively.

During the three and nine months ended September 30, 2019, time-based RSUs, performance-based RSUs and stock options to purchase approximately 5,363,000 common shares were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method. During the three and nine months ended September 30, 2018, time-based RSUs, performance-based RSUs and stock options to purchase approximately 3,750,000 and 3,979,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.